Invivyd, Inc.
IVVD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001832038
In the last 90 days, Invivyd, Inc. insiders filed 0 open-market purchases and 5 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $203.1M in total; Maverick Capital is the only superinvestor holding it.
Holders of 5% or more of IVVD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Invivyd, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Janus Henderson Group PLC | 13G/A | 12.10%25.4M shares | +0.50 ppfrom 11.60% | Sep 8, 20252 filings | Nov 14, 2025 | SEC |
| Biotechnology Value Fund L P | 13G/A | 9.99%29.6M shares | +0.99 ppfrom 9.00% | Oct 22, 20253 filings | Aug 14, 2026 | SEC |
| Adimab, LLC | 13D/A | 7.30%20.3M shares | −1.50 ppfrom 8.80% | Nov 19, 20252 filings | Dec 29, 2025 | SEC |
| Ra Capital Management, L.P. | 13G/A | 7.00%21.3M shares | −2.90 ppfrom 9.90% | Aug 29, 20253 filings | May 15, 2026 | SEC |
| Maverick Capital LtdSuperinvestorMaverick Capital | 13G/A | 6.70%19.0M shares | −1.80 ppfrom 8.50% | Aug 14, 20252 filings | Feb 13, 2026 | SEC |
| Perceptive Advisors LLC | 13G/A | 6.30%18.5M shares | −1.60 ppfrom 7.90% | Nov 25, 20252 filings | Aug 14, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.50%16.1M shares | New | Jul 28, 20261 filing | Jul 28, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
27 Schedule 13D and 13G filings on Invivyd, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20265:20 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 6.30%18.5M shares | −1.60 ppfrom 7.90% | Jun 30, 2026 | SEC |
| Aug 14, 20264:10 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 9.99%29.6M shares | +0.99 ppfrom 9.00% | Jun 30, 2026 | SEC |
| Jul 28, 20264:44 PM ET | BlackRock, Inc. | 13G | 5.50%16.1M shares | New | Jun 30, 2026 | SEC |
| May 15, 20264:42 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 7.00%21.3M shares | −2.90 ppfrom 9.90% | Mar 31, 2026 | SEC |
| May 15, 20264:25 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 0.00%43.9K shares | −6.00 ppfrom 6.00%Below 5% | Mar 31, 2026 | SEC |
| Feb 17, 20264:31 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 9.90%28.9M shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Feb 17, 20264:25 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 6.00%16.7M shares | −3.70 ppfrom 9.70% | Dec 31, 2025 | SEC |
| Feb 17, 20264:19 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 9.00%25.5M shares | +1.60 ppfrom 7.40% | Dec 31, 2025 | SEC |
| Feb 13, 20264:10 PM ET | Maverick Capital Ltdand 2 othersSuperinvestorMaverick Capital | 13G/A | 6.70%19.0M shares | −1.80 ppfrom 8.50% | Dec 31, 2025 | SEC |
| Feb 12, 20265:01 PM ET | Soleus Private Equity Fund III, L.P.and 8 others | 13G/A | 2.80%7.71M shares | −2.30 ppfrom 5.10%Below 5% | Dec 31, 2025 | SEC |
| Dec 29, 20254:15 PM ET | Adimab, LLC | 13D/A | 7.30%20.3M shares | −1.50 ppfrom 8.80% | Dec 23, 2025 | SEC |
| Nov 25, 20254:01 PM ET | Perceptive Advisors LLCand 2 others | 13G | 7.90%21.8M shares | New | Nov 18, 2025 | SEC |
| Nov 19, 20254:30 PM ET | Adimab, LLC | 13D/A | 8.80%20.5M shares | – | Nov 17, 2025 | SEC |
| Nov 14, 20254:01 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 9.70%20.4M shares | +1.70 ppfrom 8.00% | Sep 30, 2025 | SEC |
| Nov 14, 202511:55 AM ET | Janus Henderson Group PLCand 1 other | 13G/A | 12.10%25.4M shares | +0.50 ppfrom 11.60% | Sep 30, 2025 | SEC |
| Nov 14, 20258:17 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 0.00%0 shares | −8.10 ppfrom 8.10%Below 5% | Sep 30, 2025 | SEC |
| Nov 12, 20255:02 PM ET | Mithril II LPand 4 others | 13D/A | 4.80%11.2M shares | –Below 5% | Aug 22, 2025 | SEC |
| Nov 7, 20255:51 PM ET | Polaris Venture Partners V, L.P.and 10 others | 13D/A | 3.00%7.01M shares | –Below 5% | Aug 22, 2025 | SEC |
| Oct 22, 20258:00 PM ET | Biotechnology Value Fund L Pand 9 others | 13G | 7.40%16.0M shares | New | Oct 15, 2025 | SEC |
| Oct 14, 20259:03 AM ET | Soleus Private Equity Fund III, L.P.and 8 others | 13G | 5.10%10.8M shares | New | Oct 10, 2025 | SEC |
| Sep 8, 20251:07 PM ET | Janus Henderson Group PLC | 13G | 11.60%24.3M shares | New | Aug 29, 2025 | SEC |
| Aug 29, 20254:32 PM ET | Ra Capital Management, L.P.and 3 others | 13G | 9.90%21.3M shares | New | Aug 22, 2025 | SEC |
| Aug 27, 20254:18 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 8.00%16.7M shares | New | Aug 26, 2025 | SEC |
| Aug 26, 20254:15 PM ET | M28 Capital Management LPand 1 other | 13D/A | 4.60%9.55M shares | –Below 5% | Aug 22, 2025 | SEC |
| Aug 14, 20258:00 AM ET | Maverick Capital Ltdand 2 othersSuperinvestorMaverick Capital | 13G/A | 8.50%10.2M shares | – | Jun 30, 2025 | SEC |
| May 15, 20258:43 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 8.10%9.72M shares | – | Mar 31, 2025 | SEC |
| Feb 12, 20259:19 AM ET | FMR LLCand 1 other | 13G/A | 4.80%5.78M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Invivyd, Inc. shares.
No Form 144 notices for Invivyd, Inc. are on file.